These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 662842)
21. Effect of corticosterone and its route of administration on muscle protein breakdown, measured in vivo by urinary excretion of N tau-methylhistidine in rats: response to different levels of dietary protein and energy. Santidrian S; Moreyra M; Munro HN; Young VR Metabolism; 1981 Aug; 30(8):798-804. PubMed ID: 7266373 [No Abstract] [Full Text] [Related]
22. [Absence of effect of propranolol on urinary excretion of 3-methylhistidine in hyperthyroidism]. Beylot M; Riou JP; Sautot G; Mornex R Presse Med; 1984 Sep 1-8; 13(30):1829-31. PubMed ID: 6236442 [TBL] [Abstract][Full Text] [Related]
23. Muscle protein breakdown in uncontrolled diabetes as assessed by urinary 3-methylhistidine excretion. Marchesini G; Forlani G; Zoli M; Vannini P; Pisi E Diabetologia; 1982 Nov; 23(5):456-8. PubMed ID: 7173522 [TBL] [Abstract][Full Text] [Related]
24. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases. Warnes DM; Tomas FM; Ballard FJ Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447 [TBL] [Abstract][Full Text] [Related]
25. Reappraisal of the quantitative importance of non-skeletal-muscle source of N tau-methylhistidine in urine. Harris CI Biochem J; 1981 Mar; 194(3):1011-4. PubMed ID: 7306010 [TBL] [Abstract][Full Text] [Related]
26. Excretion of 3-methylhistidine by pregnant women: evidence for a biphasic system of protein metabolism in human pregnancy. Naismith DJ; Emery PW Eur J Clin Nutr; 1988 Jun; 42(6):483-9. PubMed ID: 3409856 [TBL] [Abstract][Full Text] [Related]
27. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown. Elia M; Carter A; Bacon S; Winearls CG; Smith R Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020 [TBL] [Abstract][Full Text] [Related]
28. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine. McKeran RO; Halliday D; Purkiss P J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977 [TBL] [Abstract][Full Text] [Related]
29. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease. McKeran RO; Halliday D; Purkiss P; Royston P J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561 [TBL] [Abstract][Full Text] [Related]
30. N tau-methylhistidine content of organs and tissues of cattle and an attempt to estimate fractional catabolic and synthetic rates of myofibrillar proteins of skeletal muscle during growth by measuring urinary output of N tau-methylhistidine. Nishizawa N; Toyoda Y; Noguchi T; Hareyama S; Itabashi H; Funabiki R Br J Nutr; 1979 Sep; 42(2):247-52. PubMed ID: 476040 [No Abstract] [Full Text] [Related]
31. Urinary excretion and efflux from the leg of 3-methylhistidine before and after major surgical operation. Rennie MJ; Bennegård K; Edén E; Emery PW; Lundholm K Metabolism; 1984 Mar; 33(3):250-6. PubMed ID: 6694565 [TBL] [Abstract][Full Text] [Related]
32. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine. Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577 [TBL] [Abstract][Full Text] [Related]
34. Musle protein breakdown rates in humans based on Ntau-methylhistidine (3-methylhistidine) content of mixed proteins in skeletal muscle and urinary output of Ntau-methylhistidine. Bilmazes C; Uauy R; Haverberg LN; Munro HN; Young VR Metabolism; 1978 May; 27(5):525-30. PubMed ID: 642824 [TBL] [Abstract][Full Text] [Related]
35. Ntau-Methylhistidine--an index of the true rate of myofibrillar degradation? An appraisal. Ward LC; Buttery PJ Life Sci; 1978 Sep; 23(11):1103-15. PubMed ID: 713687 [No Abstract] [Full Text] [Related]
36. Metabolism of 3-methyl histidine in experimentally induced protein-energy malnutrition in rats: urinary excretion and muscle content of 3-methyl histidine. Nagabhushan VS; Rao BS Life Sci; 1976 Mar; 18(6):639-47. PubMed ID: 817098 [No Abstract] [Full Text] [Related]
37. Urinary 3-methylhistidine derivative as indicator of nutrients intake in low-birth-weight infants. Gil A; Faus MJ; Robles R; Pita ML; Sánchez-Pozo A; Linares MD; Sánchez-Medina F Horm Metab Res; 1984 Dec; 16(12):667-70. PubMed ID: 6526369 [TBL] [Abstract][Full Text] [Related]
38. 3-Methylhistidine as a measure of skeletal muscle protein breakdown in human subjects: the case for its continued use. Ballard FJ; Tomas FM Clin Sci (Lond); 1983 Sep; 65(3):209-15. PubMed ID: 6872455 [No Abstract] [Full Text] [Related]
39. Evaluation of muscle protein breakdown in lactating cows from urinary excretion of 3-methyl histidine and plasma amino acid levels. Motyl T; Barej W; Kukulska W Z Tierphysiol Tierernahr Futtermittelkd; 1984 Feb; 51(1-2):51-7. PubMed ID: 6369830 [No Abstract] [Full Text] [Related]
40. The retention and metabolism of N tau-methylhistidine by cockerels: implications for the measurement of muscle protein breakdown determined from the excretion of N tau-methylhistidine in excreta. Harris CI; Milne G; McDiarmid R Br J Nutr; 1987 May; 57(3):467-78. PubMed ID: 3593673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]